Skip to content
10-Q

Quarterly Report

EXELIXIS, INC. EXEL

0000939767-25-000075

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 272.71M sh
Cash And Equivalents Q1 2025 · Apr 4, 2025 $183.75M
Cash And Equivalents Q1 2025 · Jan 3, 2025 $217.37M
Current Liabilities Q1 2025 · Apr 4, 2025 $399.1M
Current Liabilities Q1 2025 · Jan 3, 2025 $403.77M
Total Liabilities Q1 2025 · Apr 4, 2025 $706.22M
Total Liabilities Q1 2025 · Jan 3, 2025 $703.49M
Current Assets Q1 2025 · Apr 4, 2025 $1.4B
Current Assets Q1 2025 · Jan 3, 2025 $1.47B
Total Assets Q1 2025 · Apr 4, 2025 $2.84B
Total Assets Q1 2025 · Jan 3, 2025 $2.95B
Shares Diluted Q1 2025 · Mar 29, 2024 305.53M sh
Stock Repurchased Q1 2025 · Mar 29, 2024 $185.38M
Capex Q1 2025 · Mar 29, 2024 $9.69M
Operating Cash Flow Q1 2025 · Mar 29, 2024 $68.82M
Stockholders Equity Q1 2025 · Mar 29, 2024 $2.13B
Stockholders Equity Q1 2025 · Dec 29, 2023 $2.26B
Eps Diluted Q1 2025 · Mar 29, 2024 $0.12
Eps Basic Q1 2025 · Mar 29, 2024 $0.12
Sga Expense Q1 2025 · Mar 29, 2024 $113.98M
Rd Expense Q1 2025 · Mar 29, 2024 $227.69M
Net Income Q1 2025 · Mar 29, 2024 $37.32M
Operating Income Q1 2025 · Mar 29, 2024 $29.46M
Cost Of Revenue Q1 2025 · Mar 29, 2024 $21.26M
Revenue Q1 2025 · Mar 29, 2024 $425.23M